share_log

Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results

Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results

Hims & Hers Health | 8-K:Hims & Hers Health, Inc. 公佈2024年第二季度財務業績
美股SEC公告 ·  08/05 13:15

Moomoo AI 已提取核心訊息

Hims & Hers Health, Inc. reported strong Q2 2024 results with revenue of $315.6 million, up 52% YoY. The company achieved net income of $13.3 million, compared to a net loss of $7.2 million in Q2 2023. Adjusted EBITDA rose to $39.3 million, a 270% YoY increase.Subscribers grew to 1.9 million, up 43% YoY, while monthly online revenue per average subscriber increased 8% to $57. The company's gross margin was 81%. Operating cash flow surged 219% YoY to $53.6 million, with free cash flow up 377% to $47.6 million.Based on strong performance, Hims & Hers raised its full-year 2024 guidance to $1.37-$1.40 billion in revenue and $140-$155 million in Adjusted EBITDA. The company also announced a new $100 million share repurchase program and plans to acquire a 503B compounding outsourcing facility to support its expanding Weight Loss offerings.
Hims & Hers Health, Inc. reported strong Q2 2024 results with revenue of $315.6 million, up 52% YoY. The company achieved net income of $13.3 million, compared to a net loss of $7.2 million in Q2 2023. Adjusted EBITDA rose to $39.3 million, a 270% YoY increase.Subscribers grew to 1.9 million, up 43% YoY, while monthly online revenue per average subscriber increased 8% to $57. The company's gross margin was 81%. Operating cash flow surged 219% YoY to $53.6 million, with free cash flow up 377% to $47.6 million.Based on strong performance, Hims & Hers raised its full-year 2024 guidance to $1.37-$1.40 billion in revenue and $140-$155 million in Adjusted EBITDA. The company also announced a new $100 million share repurchase program and plans to acquire a 503B compounding outsourcing facility to support its expanding Weight Loss offerings.
Hims & HERS Health, Inc. 發佈了2024年第二季度的強勁業績,營業收入爲31560萬,同比增長52%。該公司實現了1330萬的凈利潤,相較於2023年第二季度720萬的淨虧損。調整後的EBITDA增長至3930萬,同比增長270%。訂閱用戶數增長至190萬,同比增長43%,而每位平均訂閱用戶的月在線營業收入增加8%,達57美元。公司的毛利率爲81%。經營現金流同比激增219%,達到5360萬,自由現金流同比增長377%,達到4760萬。基於強勁的表現,Hims & HERS將2024年全年的收益指引上調至13.7億至14億美元,調整後的EBITDA爲1.4億至15500萬美元。該公司還宣佈了一項新的10000萬美元股票回購計劃,並計劃收購一個5030億的複合外包設施,以支持其不斷擴展的減肥產品。
Hims & HERS Health, Inc. 發佈了2024年第二季度的強勁業績,營業收入爲31560萬,同比增長52%。該公司實現了1330萬的凈利潤,相較於2023年第二季度720萬的淨虧損。調整後的EBITDA增長至3930萬,同比增長270%。訂閱用戶數增長至190萬,同比增長43%,而每位平均訂閱用戶的月在線營業收入增加8%,達57美元。公司的毛利率爲81%。經營現金流同比激增219%,達到5360萬,自由現金流同比增長377%,達到4760萬。基於強勁的表現,Hims & HERS將2024年全年的收益指引上調至13.7億至14億美元,調整後的EBITDA爲1.4億至15500萬美元。該公司還宣佈了一項新的10000萬美元股票回購計劃,並計劃收購一個5030億的複合外包設施,以支持其不斷擴展的減肥產品。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息